IL163608A0 - Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders - Google Patents

Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders

Info

Publication number
IL163608A0
IL163608A0 IL16360803A IL16360803A IL163608A0 IL 163608 A0 IL163608 A0 IL 163608A0 IL 16360803 A IL16360803 A IL 16360803A IL 16360803 A IL16360803 A IL 16360803A IL 163608 A0 IL163608 A0 IL 163608A0
Authority
IL
Israel
Prior art keywords
derivatives
amino
proliferative disorders
treating proliferative
sulfonanilides
Prior art date
Application number
IL16360803A
Other languages
English (en)
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Publication of IL163608A0 publication Critical patent/IL163608A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/27—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL16360803A 2002-02-28 2003-02-28 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders IL163608A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36071002P 2002-02-28 2002-02-28
PCT/US2003/006358 WO2003072063A2 (en) 2002-02-28 2003-02-28 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders

Publications (1)

Publication Number Publication Date
IL163608A0 true IL163608A0 (en) 2005-12-18

Family

ID=27766241

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16360803A IL163608A0 (en) 2002-02-28 2003-02-28 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
IL163608A IL163608A (en) 2002-02-28 2004-08-18 Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL163608A IL163608A (en) 2002-02-28 2004-08-18 Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders

Country Status (8)

Country Link
US (1) US7161031B2 (xx)
EP (1) EP1534284B1 (xx)
JP (1) JP4538233B2 (xx)
AT (1) ATE517626T1 (xx)
AU (1) AU2003213661A1 (xx)
CA (1) CA2477236C (xx)
IL (2) IL163608A0 (xx)
WO (1) WO2003072063A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767926B1 (en) * 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
JP4588323B2 (ja) * 2002-02-28 2010-12-01 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 増殖性疾患を治療するためのアミノ置換（ｅ）−２，６−ジアルコキシスチリル−４−置換ベンジルスルホン
EA200901236A1 (ru) * 2004-03-16 2009-12-30 Темпл Юниверсити - Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Замещённые фенокси- и фенилтиопроизводные для лечения пролиферативных нарушений
JP4982364B2 (ja) * 2004-07-19 2012-07-25 オンコノバ セラピューティクス インコーポレイテッド （ｅ）−２，６−ジアルキルオキシスチリル４−置換ベンジルスルフォン非経口用投与用製剤
AU2006204103B2 (en) * 2005-01-05 2011-11-24 Temple University Of The Commonwealth System Of Higher Education Treatment of drug-resistant proliferative disorders
WO2007118852A1 (en) * 2006-04-13 2007-10-25 Glaxo Group Limited Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
US20090191193A1 (en) * 2006-08-02 2009-07-30 Temple University-Of The Commonwealth System Of Higher Education Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof
JP5278968B2 (ja) * 2006-08-30 2013-09-04 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 骨髄異形性症候群及び急性骨髄性白血病の治療のための組成物及び方法
GB0617865D0 (en) * 2006-09-11 2006-10-18 Glaxo Group Ltd Novel use
WO2008033475A2 (en) * 2006-09-15 2008-03-20 Onconova Therapeutics, Inc. Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions
AU2013318206B2 (en) 2012-09-20 2018-07-26 Temple University - Of The Commonwealth System Of Higher Education Substituted alkyl diaryl derivatives, methods of preparation and uses
US10383831B2 (en) 2015-08-03 2019-08-20 Temple University—Of the Commonwealth System of Higher Education 2,4,6-trialkoxystryl aryl sulfones, sulfonamides and carboxamides, and methods of preparation and use

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2531367A (en) 1947-07-15 1950-11-21 Sharp & Dohme Inc N-(substituted sulfonyl)-aminobenzoic acids
DE2118493C3 (de) 1971-04-16 1980-04-30 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Aminostilbenen
US4035421A (en) 1976-03-19 1977-07-12 Morton-Norwich Products, Inc. N-(3,4,-dichlorophenyl)-2-phenylethenesulfonamide
DE2809377A1 (de) 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
IL98784A0 (en) 1990-07-17 1992-07-15 Lilly Co Eli Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them
JPH04202173A (ja) 1990-11-30 1992-07-22 Zeria Pharmaceut Co Ltd スルホンアミド誘導体及びそれを含有する５―リポキシゲナーゼ阻害剤
WO1995024190A2 (en) 1994-03-07 1995-09-14 Sugen, Inc. Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
US5780483A (en) 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
WO1996025157A1 (en) 1995-02-17 1996-08-22 Smithkline Beecham Corporation Il-8 receptor antagonists
DK0896533T3 (da) 1996-02-22 2004-01-26 Tularik Inc Pentafluorbenzensulfonamider og analoger
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
US6548553B2 (en) 1997-10-03 2003-04-15 Temple University-Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
RU2201919C2 (ru) 1997-10-03 2003-04-10 Темпл Юниверсити Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Стирилсульфоновые соединения, фармацевтические композиции на их основе, способ ингибирования роста опухолевых клеток, способ индукции апоптоза опухолевых клеток и способ лечения
US6191170B1 (en) 1998-01-13 2001-02-20 Tularik Inc. Benzenesulfonamides and benzamides as therapeutic agents
GB9811427D0 (en) * 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
KR100642184B1 (ko) 1998-09-23 2006-11-10 암젠 인크 아릴술폰아닐리드 우레아
US6762207B1 (en) 1999-04-02 2004-07-13 Temple University - Of The Commonwealth System Of Higher Education (E)-styryl sulfone anticancer agents
US6586617B1 (en) 1999-04-28 2003-07-01 Sumitomo Chemical Takeda Agro Company, Limited Sulfonamide derivatives
US6767926B1 (en) 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
GB9924522D0 (en) * 1999-10-15 1999-12-15 Arrow Therapeutics Ltd Enzyme inhibitors
US6486210B2 (en) 2000-04-14 2002-11-26 Temple University—Of the Commonwealth System of Higher Education Substituted styryl benzylsulfones for treating proliferative disorders
US6541475B2 (en) 2000-04-14 2003-04-01 Temple University - Of The Commonwealth System Of Higher Education α, β-unsaturated sulfones for treating proliferative disorders
EP1328511B1 (en) 2000-10-05 2010-03-24 Temple University of the Commonwealth System of Higher Education Substituted (e)-styryl benzylsulfones for treating proliferative disorders
WO2002067865A2 (en) * 2001-02-28 2002-09-06 Temple University Of The Commonwealth System Of Higher Education N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
US6667346B2 (en) 2001-02-28 2003-12-23 Temple University - Of The Commonwealth System Of Higher Education Method for protecting cells and tissues from ionizing radiation toxicity with α, β unsaturated aryl sulfones
IL158593A0 (en) * 2001-05-11 2004-05-12 Biovitrum Ab Novel, arylsulfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
JP4588323B2 (ja) 2002-02-28 2010-12-01 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 増殖性疾患を治療するためのアミノ置換（ｅ）−２，６−ジアルコキシスチリル−４−置換ベンジルスルホン

Also Published As

Publication number Publication date
CA2477236C (en) 2013-08-13
AU2003213661A1 (en) 2003-09-09
US20050096484A1 (en) 2005-05-05
WO2003072063A3 (en) 2005-04-07
AU2003213661A8 (en) 2003-09-09
EP1534284A4 (en) 2006-08-16
ATE517626T1 (de) 2011-08-15
WO2003072063A2 (en) 2003-09-04
EP1534284A2 (en) 2005-06-01
JP4538233B2 (ja) 2010-09-08
US7161031B2 (en) 2007-01-09
CA2477236A1 (en) 2003-09-04
IL163608A (en) 2013-12-31
JP2005528345A (ja) 2005-09-22
EP1534284B1 (en) 2011-07-27

Similar Documents

Publication Publication Date Title
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
MXPA04005456A (es) Derivados de acetileno que tienen actividad antagonistica de mglur5.
MXPA02008056A (es) Derivados de 2-oxo-1 pirrolidina, proceso para prepararlos y sus aplicaciones.
AU7779900A (en) Trifluoromethyl-substituted spirocyclic ketoenols
AU2002239344A1 (en) Pyrazolopyridines
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA04004107A (es) Moleculas pequenas para el tratamiento del crecimiento celular anormal.
WO2003072062A3 (en) Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
EA200400466A1 (ru) Производные пиперазина с антагонистической активностью к рецептору ccr1
AU2003228674A1 (en) Muscarinic antagonists
HK1085675A1 (en) Anticancer compounds
DE60112330D1 (en) Pyrazolopyridinderivate
CA2453917A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
AU2003213661A8 (en) Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
MXPA02009549A (es) Imidazopiridinas triciclicas.
IL157050A0 (en) 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
AU2002248531A1 (en) Pyrazolopyriadine derivatives
DE60001366D1 (de) Orale zusammensetzung enthaltend perlit
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
YU46302A (sh) Supstituisani piroli
NZ511997A (en) Isonipecotamides for the treatment of integrin-mediated disorders